Function of the P2X7 receptor in hematopoiesis and leukemogenesis

Xiaoxiao He1, Yaping Zhang1, Yilu Xu1

  • 1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Experimental Hematology
|October 23, 2021
PubMed

Insights

Adenosine triphosphate (ATP) and its P2X7 receptor are crucial in normal blood cell development and leukemia. Increased ATP in the bone marrow niche impacts acute myeloid leukemia cell fate, suggesting P2X7 receptor as a potential cancer biomarker and therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Hematology

Background:

  • Adenosine triphosphate (ATP) accumulates at sites of tissue injury and inflammation.
  • The P2X7 receptor, an ATP-gated ion channel, exhibits cytotoxic activity but also influences cancer growth and immune regulation.
  • P2X7 receptor is expressed in hematopoietic stem cells and their lineages, playing roles in physiological and pathological processes.

Purpose of the Study:

  • To summarize the biological functions of the P2X7 receptor in normal hematopoiesis and leukemogenesis.
  • To investigate the role of ATP-P2X7 signaling in the leukemic bone marrow niche.

Main Methods:

  • Literature review on P2X7 receptor functions.
  • Analysis of ATP levels in leukemic bone marrow niches.
  • Assessment of P2X7 receptor expression and signaling in leukemia-initiating cells.

Main Results:

  • ATP levels are significantly elevated in the leukemic bone marrow niche.
  • Leukemia-initiating cell fates in acute myeloid leukemia are regulated by P2X7 receptor expression and ATP-P2X7 signaling.
  • P2X7 receptor is essential for normal hematopoiesis and leukemogenesis.

Conclusions:

  • The P2X7 receptor plays a critical role in both normal hematopoiesis and leukemogenesis.
  • The P2X7 receptor may serve as a biomarker for hematological malignancies within bone marrow niches.
  • P2X7 receptor antagonists show potential as adjunct therapies for leukemia treatment.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.9K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.4K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.5K